36406-91-4 Usage
Uses
Used in Chemical Synthesis:
3-Bromo-4,5-dichloroaniline is used as an intermediate in the production of dyes, pharmaceuticals, and agrochemicals. It serves as a building block in the development of new chemical compounds, contributing to the synthesis of various organic molecules.
Used in Organic Synthesis:
3-Bromo-4,5-dichloroaniline is used as a reagent in organic synthesis, facilitating the formation of complex organic molecules through chemical reactions. Its unique structure allows it to participate in a variety of reactions, making it a valuable component in the synthesis of specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-bromo-4,5-dichloroaniline is used as a precursor for the synthesis of certain drugs. Its specific functional groups enable the creation of medicinal compounds with targeted therapeutic effects.
Used in Agrochemical Industry:
3-Bromo-4,5-dichloroaniline is also utilized in the agrochemical industry, where it serves as a starting material for the synthesis of various pesticides and other agricultural chemicals. Its properties allow for the development of effective products to protect crops and enhance agricultural productivity.
Safety Precautions:
It is important to handle 3-bromo-4,5-dichloroaniline with caution, as it is considered hazardous and may cause irritation to the skin, eyes, and respiratory system. Proper safety measures should be taken during its use to minimize potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 36406-91-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,4,0 and 6 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 36406-91:
(7*3)+(6*6)+(5*4)+(4*0)+(3*6)+(2*9)+(1*1)=114
114 % 10 = 4
So 36406-91-4 is a valid CAS Registry Number.
36406-91-4Relevant academic research and scientific papers
CHEMICAL COMPOUNDS
-
Paragraph 0348; 0822-0823, (2019/06/20)
The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
